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Highlights 
 We propose a framework to evaluate health policy changes against health system goals. 
 The framework provides a categorisation of policies into distinct health system domains. 
 Policies are evaluated in terms of their effect on efficiency and equity. 
 Policy changes implemented in European countries since 2008 illustrate the framework. 
 Policies mainly aimed to contain cost and likely had mixed effects on efficiency and equity. 
 
Abstract 
The objective of this paper is to provide a framework for evaluation of changes in health policy 
against overarching health system goals. We propose a categorisation of policies into seven distinct 
health system domains. We then develop existing analytical concepts of insurance coverage and 
cost-effectiveness further to evaluate the effects of policies in each domain on equity and efficiency. 
The framework is illustrated with likely effects of policy changes implemented in a sample of 
European countries since 2008. Our illustrative analysis suggests that cost containment has been the 
main focus and that countries have implemented a mix of measures that are efficient or efficiency 
neutral. Similarly, policies are likely to have mixed effects on equity. Additional user charges were a 
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common theme but these were frequently accompanied by additional exemptions, making their 
likely effects on equity difficult to evaluate. We provide a framework for future, and more detailed, 
evaluations of changes in health policy.   
Keywords 
Healthcare Reform; Equity; Efficiency; Economic Crisis; Europe; Denmark; England; France; Italy; 
Netherlands; Portugal; Spain 
  
3 
 
Introduction 
The need to “bend the cost curve” and lower the rate of growth in healthcare spending has been 
acknowledged across many high-income countries. The post-2008 economic crisis, which 
precipitated a sovereign debt crisis in Europe and squeezed public budgets, added particular urgency 
to longer-term concerns of cost containment. 
Questions policy makers face in an environment of short-term pressures to contain costs may 
include: Where should cost containment be targeted to avoid undermining health system 
performance? Should policies aim at controlling prices or volumes? Which measures can generate 
short-term savings and what are their long-term implications? Which measures require significant 
up-front financial investment or are technically demanding? Which measures are politically difficult 
to adopt? 
The intended or unintended consequences of policy changes in response to external shocks can be 
evaluated against overarching health system goals. Protection of high-need and vulnerable 
populations, such as the elderly, people with low incomes or social minorities, who tend to be 
characterised by lower health status and a disproportionate prevalence of illness, remains a priority 
across all three of these. Although evidence on the effects of economic crises on health and the 
demand for healthcare remains ambiguous [1], the number of vulnerable people likely increases 
with economic downturn and increasing unemployment. At the same time, declines in government 
revenue and private incomes cause pressure on public and private budgets available for healthcare 
[2]. In deciding which policy responses to adopt, equitable financing and access to healthcare are 
particularly important to protect vulnerable groups. 
The objective of this paper is to provide a framework for evaluation of health policy changes against 
overarching health system goals. The first section develops the framework. We then extract from 
prior studies policies implemented in a sample of European countries since 2008. We evaluate and 
discuss the likely effects of these policies to illustrate our framework. A wide range of changes were 
made in this period, either in response to the economic crisis or in continuation of existing priorities 
[3,4], providing a rich sample of policies to illustrate our framework.  
Framework Development 
The World Health Organization (WHO) health system goals of improving population health, 
maintaining health services and ensuring fair financing and financial protection from ill-health [5] are 
related to the more abstract concepts of efficiency and equity. Improvement of population health 
requires the provision of effective services. With any given amount of finite resources, their 
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allocation to interventions that provide the greatest health gain will increase effectiveness and, by 
increasing health gains per unit of expenditure, efficiency. 
Fair or equitable financing and financial protection are achieved by insurance that levies prepaid 
contributions progressively, based on ability to pay rather than risk of future service use, and leaving 
services free of charge at the point of use. Equity of access to services, that is, equal access for equal 
need regardless of ability to pay [6,7], ensures that services are responsive to population need. 
Overall, a healthcare system is redistributive if progressive financing is combined with equity of 
access, and incidence of public spending is higher in poorer population groups with higher need [8]. 
The criteria in an evaluation of equity are thus twofold, “Who pays (contributions)?”, and “Who gets 
(benefits)”? 
A third and related question is, “Who gets paid?” This arises from the identity of aggregate revenue 
raised with aggregate healthcare expenditure and aggregate income of those working in the 
healthcare sector. Revenue and expenditure are equal to the volume of healthcare services 
delivered to the population multiplied by their average price and equal to the number of people 
working in health care multiplied by their average incomes [9]. 
We first extend the framework of the three dimensions of coverage by WHO [10] to analyse the 
effect of policies on insurance coverage (Figure 1). As has been suggested by Roberts, Hsiao & Reich 
[11], the depth and height of coverage may vary across population groups so that a homogeneous 
coverage "cube" is of limited use in an analysis of equity. This may be particularly true in low- and 
middle-income countries but also applies in high-income countries if coverage depends on location 
or occupation [8] or certain population groups are excluded or can opt out of public coverage [12]. 
Therefore, policies are evaluated in terms of their effect on service and cost coverage for distinct 
population groups. Reductions in coverage overall or policies that increase the gap in coverage 
between population groups have a negative effect on equity; policies that increase coverage or 
reduce coverage gaps increase equity. Along the height of coverage we furthermore distinguish 
between value-based users charges that may facilitate efficiency gains and blanket charges, which 
reduce equity.  
We then categorise policies according to where in the tri-partite relationship between patients, 
purchasers and providers [13] their effects lie (Figure 2). In each of these health system domains, a 
set of criteria are used to evaluate the effect of policies on equity and efficiency. These include the 
breadth and depth of insurance coverage as criteria in financial flows from the population to 
purchasers (boxes 1 and 2). The height of coverage is the criterion in direct payments from the 
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population to providers (box 3). Beyond coverage, the main criteria in risk adjustment between 
purchasers and in resource allocation to providers are incentives for risk-selection and for changing 
the volume and quality of services (box 4). The effect of these financial flows on provider behaviour 
(box 5) and on equity of access (box 6) are the main criteria in service provision to the population. A 
final domain is added for policies related to the health system in its entirety (box 7). The amount of 
administrative cost incurred for health system stewardship impacts efficiency in this domain. 
Finally, we expand upon the framework proposed by Thomson et al. [14] and borrow from a 
framework referred to as the “cost-effectiveness plane” in the health economics literature [15]. This 
allows for a visualisation of the effects of policies on efficiency. While efficiency is frequently 
misconstrued as synonymous with cost reductions, the concept requires a measure of output as 
numerator in addition to a measure of cost as denominator. Health outcomes attributable to 
healthcare (such as amenable mortality) are appropriate numerators in measuring efficiency 
because increasing population health is an overall policy goal. However, the effect of healthcare is 
notoriously difficult to disentangle from the wider determinants of health. As a result, assuming that 
services are effective in improving health, aggregate volumes of services provided can be used as a 
surrogate measure.  
The third element of our framework is presented graphically in Figure 3. Policies are placed along the 
horizontal axis based on their effect on health expenditure. This is measured in terms of total 
expenditure, whether financed publicly or privately, to distinguish cost containment from cost 
shifting. Cuts in public expenditure may lead to substitution of public with private sources of 
financing [16–18]. Such cost-shifting measures may be particularly harmful to equity and lead to 
increased aggregate expenditure because cost is more difficult to contain when financed by 
fragmented private sources than in an environment of monopsonistic purchasing. Along the vertical 
axis, policies are placed on the plane based on their effect on health outcomes or aggregate service 
volumes. 
If effects on outcomes or output can be measured on a ratio scale and sufficient data on effects and 
costs are available, this allows for ranking of distinct policies based on efficiency and their relative 
positions on the plane are a visualisation of their relative effects on efficiency. For example, a policy 
in the top-right quadrant close to the origin of both axes is more efficient than a policy in same 
quadrant and further right but equally close to the horizontal axis. However, only policies that 
increase output and decrease cost clearly represent efficiency gains while measures that decrease 
output and increase cost are clearly inefficient. Measures in the remaining two quadrants, which 
decrease or increase both cost and output concurrently, may be efficiency-neutral, efficient or 
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inefficient. The frontier between efficiency and inefficiency is represented by the dotted line in 
Figure 3. The slope of this line represents the incremental amount of resources a society is willing to 
expend for obtaining an incremental unit of service output or health gain. This is an external 
threshold set by policy.  
A similar plane with a measure of equity on the vertical axis can be used to visualise relative equity 
effects. The direction of equity effects of changes to coverage are relatively straightforward to assess 
along the three dimensions illustrated in Figure 1. Determining the effects of other policies on equity 
and the position of policies on the plane relative to each other is empirically more difficult.  
Methods 
We extract all policies in Denmark, England, France, Italy, the Netherlands, Portugal and Spain from 
results of surveys and case studies published by the European Observatory on Health Systems and 
Policies [3,4]. We abstract the stated or implicit goals of each policy, which provider, profession, 
health technology or population group it affects and the mechanism through which it aims to 
achieve its goals and group policies that are identical according to these criteria across countries. 
Using the conceptual framework described above, we categorise these distinct types of policies 
according to the seven health system domains and assess their likely effects against health system 
goals. We cluster distinct policy types according to the type and direction of their likely effect and 
populate the efficiency plane with the policy clusters. We also discuss effects on equity and replicate 
the efficiency plane with equity on the vertical axis. 
Our methods have a number of limitations. First, we categorise policies according to the direction of 
their likely effects because no detailed data on their actual effects on cost and output are available. 
We discuss some key assumptions made in our categorisations below. We also restrict our analysis 
to a static environment and do not consider all potential longer-term effects of policies. Because 
policy clusters are placed into quadrants based only on the likely direction of their effects, their 
relative positions within each quadrant cannot be interpreted in terms of their relative effects on 
efficiency or equity. Second, we use service output in assessing efficiency because too many 
assumptions would be necessary to assess likely effects on health outcomes. Finally, at the risk of 
some oversimplification but in order to cover the complete range of policies in the graphical 
representations, we only show the 21 policy clusters in the efficiency and equity planes. Performing 
the analysis at the level of distinct policy types, or indeed individual policies by country, would allow 
for a more nuanced categorisation. 
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The seven countries included experienced varying degrees of economic downturn and cuts to public 
budgets since 2008 and provide a wide variety of policies. They further represent two countries 
(Denmark and England) outside and four inside the European Monetary Union, of which Portugal 
and Spain were subject to Economic Adjustment Programs (EAPs) under supervision of the European 
Commission, the European Central Bank and the International Monetary Fund. Italy was also under 
scrutiny and pressure from creditors to cut public expenditure while France remained less affected 
by such external forces. The urgency to reform and to find measures with immediate effects can 
thus be assumed to have varied significantly between these countries. 
Results 
We define 45 distinct types of policies since 2008 from the studies conducted by the European 
Observatory [3,4] across 21 clusters. All policies and their categorisation are shown in Appendix 1. 
Some policies were direct responses to the economic crisis, particularly in southern European 
countries, which were impacted most severely by the crisis and where policy was subject to EAPs, 
while others represented a continuation of ongoing fiscal consolidation and reform processes.  
Twenty-six of 45 policy types were related to changes in coverage and accessibility of publicly 
funded healthcare, with some changes to breadth (Who pays?) but focusing on the depth and height 
of coverage (Who gets?). Twelve related to changes in user charges, i.e. the height of coverage. 
Among the remaining 19, eight were related to changes in provider payment or prices (i.e. price 
reductions – Who gets paid?), five to changes in provider structure or in procurement of provider 
supplies, five were directly related to changes in service provision or the quality of services and one 
was related to changes in ministries or other government agencies, affecting stewardship of the 
entire health system.  
Figure 4 shows the mapping of policy clusters on the efficiency and equity planes based on their 
likely effects. Colour codes indicate which domain of the health system and which dimension of 
coverage each policy is related to. Policies spanned six of seven health system domains in Denmark, 
France, the Netherlands and Spain and five domains in Italy and Portugal. Most policies likely 
represented cost containment and fall into the left-hand quadrants of the planes. However, some 
policies have likely led to cost increases and concurrent increases in output and equity. Although 
some policies may be inefficient in the longer run through causing delayed cost increases, our 
analysis does not identify clearly inefficient policies that are likely to decrease output while 
increasing cost in the short run. Somewhat of an exception to this may be increases to user charges 
for primary care, which were reported in two countries (Appendix 2).  
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The highest number of policy types was adopted in the Netherlands, covering all except the bottom-
right efficiency quadrants. In Denmark, the majority of initiatives aimed to reduce cost while being 
neutral to or also reducing output, making their impact on efficiency difficult to evaluate; changes 
also aimed to improve quality and expanded coverage of preventive interventions for vulnerable 
populations. A number of measures were reported in France that are likely to increase quality, such 
as value-based user charges and expansion of HTA, and increase efficiency, such as substitution of 
inpatient with outpatient care. Initiatives also included increases in user charges as well as expansion 
of protection schemes to low-income populations. Similarly, all three southern European countries 
took measures across all except the bottom-right quadrants. England, where the fewest policies 
were adopted spanning four of seven health system domains, appears to be somewhat of an 
exception – neither policies that might increase cost were reported nor, contrary to other countries, 
were additional user charges introduced. Policies in England appear to have focused on cutting 
provider prices and incomes, downsizing administrative bodies and gaining efficiencies from 
substituting hospital services. 
Fourteen of the 26 policy types related to coverage reduced the breadth, depth or height, implying 
negative effects on equity (Appendix 1). Coverage reductions for vulnerable groups, such as 
immigrants in Spain, are likely to have a particularly detrimental effect on equity because they also 
increase the coverage gap between population groups. However, three types of policies increased 
coverage for vulnerable populations either through expanding coverage to population groups that 
were previously uninsured, removing user charges or expanding user charge exemptions. 
User charge increases were most commonly applied to hospital or specialist services and drugs or 
devices and most frequently took the form of co-payments (Appendix 2). A mandatory deductible 
across all types of services only applies in the Netherlands, with some exceptions such as primary 
care consultations. Co-insurance predominantly applies to drugs and devices, which may provide 
patients incentives to choose cheaper alternatives [19]. France introduced value-based co-insurance 
to penalise utilisation of care not compliant with agreed pathways. To attenuate effects of user 
charges on low-income and high-need populations, introductions or increases were generally 
accompanied by expansion of exemptions (Appendix 3). In Denmark, France and Italy initial changes 
to user charges were reversed at later points in time during the period considered, or subsequently 
included in the overall deductible in the Netherlands.  
Some of the initiatives that are likely to increase efficiency can also be positive for equity. The 
reduction of drug prices, through mechanisms such as generic substitution, for example, can reduce 
financial access barriers. Substituting hospital with primary care can increase equity if primary care is 
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more accessible to poorer and needier population groups than specialised care. Cost containment 
measures that are output neutral are likely to also be neutral to equity. 
Discussion 
It is not always straightforward to assess the likely effects of policies on cost and output without 
detailed empirical evidence on their design and actual effects, which is largely lacking. Effects on the 
health system goals considered may indeed depend significantly on the design and implementation 
of policies or their context. Reductions in drug prices, for example, could reduce cost and be output-
neutral but might also increase output if drugs become more affordable, as has been reported in the 
Netherlands or Portugal [20,21]. We consider reductions in provider prices and overhead to be 
efficient through reducing costs and leaving output unchanged. This is also true if providers respond 
with an increase in activity. If cuts are excessive, however, making some activity economically 
unviable, they may also be associated with reductions in service volumes. A similar dynamic may 
apply to cutting health worker incomes – if cuts are substantial, service volumes and quality may 
decrease. If young professionals are affected disproportionately, income cuts may also imply 
negative effects on workforce morale in the longer run and make health professions less attractive. 
Measures such as the introduction of evidence-based guidelines and monitoring of adherence, 
expansion of e-health systems, introduction of value-based user charges or health technology 
assessment (HTA) to define coverage are likely to improve the quality of services and, potentially, 
health outcomes achieved. While this can reduce the use of services with little benefit and create 
savings, it may also uncover unmet need and encourage the additional use of effective services 
leading to cost increases. 
Finally, measures that aim to change the mix of services or the skill mix of the workforce, such as 
substituting doctors with nurses, may also generate savings even if service volumes remain 
unchanged. If designed carefully to make service delivery more appropriate to patient need and 
provider skills, output and quality may increase. However, the ultimate effects of shifting tasks from 
doctors to other professionals depend on the context in which they are implemented and on the 
reactions of professionals. Doctors wield significant power in provider organisations, especially in 
primary care, and may be able to capture savings from substitution of skills as additional income if 
provider payments are not lowered concurrently. They could also react by inducing demand for 
additional services to substitute lost income.  
Similarly, not all initiatives can easily be assessed in terms of equity. Measures that aim to reduce 
service volumes are equity-neutral if reductions are proportionate to population need. However, if 
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they are concentrated in areas of higher need or providers respond to price reductions or volume 
caps with shifting activity towards lower-risk or private patients, such measures reduce equity. 
Quality improvement measures can be equity-neutral provided that they improve quality of care for 
all population groups proportionately to need. They can indeed have a positive effect if they render 
appropriate care more accessible to high-need patients. Conversely, they can be detrimental to 
equity if improvements occur disproportionately for groups with lower need. There is a risk that 
disadvantaged population groups that are politically less well represented are affected 
disproportionately in times of austerity while more affluent groups are able to protect themselves. 
Without more detailed analysis and disaggregated data, it is not possible to assess the de facto 
effects of these measures on vulnerable populations. 
These limitations notwithstanding, Figure 4 illustrates that, based on our analysis, policies cluster to 
the left of the efficiency plane and are likely to contain cost through cuts to capacity and activity and 
attendant changes to coverage or price reductions. Many policies thus represent mechanisms to 
reduce costs and activity concurrently. However, countries also appear to have used the crisis as an 
opportunity to increase spending in some areas through expanding population and service coverage. 
Price cuts, reported in all seven countries, are a means to reduce total expenditure through reducing 
provider incomes (Who gets paid?) and without reducing volumes (Who gets?). As economic activity 
slows, revenue decreases without changing contribution rates (Who pays?). Price reductions, 
whether affecting provider incomes or industry supplying providers, can generate immediate savings 
to realign expenditure with revenue and are relatively easy to implement technically. Although 
political resistance might be encountered if those bearing the brunt of such measures have strong 
representations, these may be ‘low-hanging fruit’ and be relatively ‘painless’ for the population [22]. 
Price cuts can also be neutral to equity, provided that they are not excessive and result in de facto 
reductions in service availability. 
Reductions in prices of pharmaceuticals or generic substitution were reported in all countries, with a 
particularly wide range of measures in Portugal and Spain [31–33]. Aggregate data indicate that 
pharmaceutical sales have slowed or decreased while volumes of major drug categories have 
continued to increase, as has the share of generics [29,30]. While our conceptual analysis does not 
establish causal relationships, this could be an indication that policies may indeed have achieved 
efficiencies. However, more specific studies from Spain indicate that increased co-payments reduced 
pharmaceutical consumption [34,35]. 
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While also technically easy to implement, direct cuts to the availability of services are more ‘painful’ 
for the population [22]. Such measures include hospital closures, reduction of staff or other cuts to 
capacity. They may be politically more problematic and have a more immediate effect on health 
system performance. Their distributional implications depend on which population groups are 
affected more by the cuts (Who Gets?). Policies to control the number or incomes of healthcare 
workers were reported in all countries and were particularly prominent in southern Europe. Studies 
of perceived impacts of cuts in Spain and Italy raised concerns about deteriorating working 
conditions, patient access and quality of care [23–26]. Sources from Portugal, for example, where 
salaries and benefits of staff at public providers were reduced significantly, indicate that doctors and 
nurses increasingly resort to private-sector jobs or to practicing abroad [3,27]. In Spain, salary cuts 
were of similar magnitude [28] and have been reported to have negative effects on workforce 
morale and on quality of care [23]. However, there appears to be continued growth in the number of 
active physicians and nurses per population in all countries for which such data is reported [29,30]. 
The introduction of access barriers, notably through additional user charges, was common. This is 
concerning as they imply an immediate reduction in equity through making services less available to 
vulnerable population groups. In addition, prior evidence has shown clearly that blanket user 
charges are a blunt mechanism and may not only be inequitable but also inefficient in the longer run 
[19,31]. This is particularly true for primary care because, depending on the barriers to accessing 
other levels of care, such charges could cause people to substitute primary with more expensive care, 
such as hospital-based services, or to forgo early treatment causing utilisation of costlier 
interventions at a later stage (‘squeezed-balloon effect’). While our analysis does not consider 
longer-term effects, a similar dynamic could apply to several policies that are likely to reduce cost 
and output concurrently in the short run. The reduced availability of necessary services could have 
the unintended consequences of contributing to the growth of a parallel private sector, reducing 
equity, and lead to cost increases in the longer-term. 
Decreases in hospital discharges and length of stay as well as increases in unmet need and waiting 
times might be an indication of reduced accessibility of services and are apparent in southern 
European countries and, to a lesser extent, in the UK [29,30,32]. However, increases in user charges 
have largely been accompanied by additional exemptions. In Portugal, for example, eligibility for 
exemptions was broadened from about 4.2 to 7.2 million people [33]. We are not able to assess the 
likely effects of user charge increases combined with additional exemptions.  
The introduction of value-based user charges was only reported in France and Italy. This may 
represent a missed opportunity. If applied carefully, such charges can reduce the use of 
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inappropriate care while freeing up resources for needed services and can thus have equity and 
efficiency-enhancing effects [34]. Value-based policies more generally, such as expanding HTA, were 
less common and might still be in their infancy. One reason for this may be that such policies are 
technically more difficult to implement, require up-front investment and may not generate 
immediate savings. A number of measures for HTA-based cuts to service coverage were announced 
in Spain but these take time to be implemented [35,36].  
While the period since 2008 provides a rich sample of policy changes, our analysis does not attempt 
to attribute effects that were observed by empirical studies to specific policies. Nor does the recency 
of policy changes allow for evaluating more sustained effects on health system goals, which 
materialize with delay. We find, for example, a larger number of policy types in the Netherlands than 
in England. This does not imply, however, that cost containment was more pronounced in the 
Netherlands. Indeed, in England, the crisis coincided with significant reforms under the 2012 Health 
and Social Care Act that increased autonomy of devolved purchasers and may have led, together 
with flat budget allocations, to reductions in service accessibility that are not immediately apparent 
from national policy. Actual effects depend on goals set by policy makers and the design of policies, 
which were more radical in southern European countries that were severely hit by the crisis and 
were subject to external pressures. More generally, evidence on effects of specific policies 
implemented during the post-2008 crisis is sparse. As a result, our analysis relies on descriptions of 
policies in a convenience sample of European countries that serve to illustrate our framework based 
on a number of assumptions and their likely effects.  
 
Conclusion 
We provide a conceptual framework for future and more detailed evaluations of the effects of 
health policy changes on efficiency and equity. The framework is illustrated with likely effects of 
recent policies from Denmark, England, France, Italy, the Netherlands, Portugal and Spain.  
Responses to the most recent economic crisis may have had a greater cost containment focus than 
before [17]. Measures that are relatively easy to implement were common and are may have 
contained cost while preserving accessibility of services in the short-run, implying efficiency gains. 
However, a large number of policies also aimed to cut costs by restricting coverage and access, 
which is likely to decrease equity and has uncertain effects on efficiency, especially in the longer 
term. Increases in user charges were a common theme. 
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Appendices 
Appendix 1: Summary and categorisation of policies implemented since 2008 in the six countries reviewed 
Health System 
Domain Affected 
Type of Effect 
Direction of Effect on 
Description of Policy Type Countries 
Output Equity Cost 
Population 
coverage (breath) 
and access to 
services 
Increase breadth + + + 1. Expanding coverage for uninsured population or vulnerable groups France, Spain 
Reduce breadth - - - 
2. Restricting coverage for vulnerable groups (e.g. non-permanent residents, non-
EU citizens, undocumented migrants, etc.) 
Spain 
3. Tightening of eligibility criteria for long-term care, resulting in de-facto 
narrowing of population coverage 
Netherlands 
Service coverage 
(depth) and 
access 
 
Increase depth + + + 
4. Ad-hoc expansion of coverage for additional services France, Netherlands, Italy 
5. Increasing public health budgets or expanding public health interventions 
(screening, prevention) 
Denmark, France, 
Portugal 
Reduce depth - - - 
6. Ad-hoc or blanket restrictions to coverage of services  Netherlands, Spain, Italy, 
Portugal 
7. Reducing public health budgets or removing public health interventions 
(screening, prevention) 
Denmark, Netherlands 
8. Reducing supply and accessibility of primary care Spain 
9. Reducing supply of hospital care (closures, reduction in beds, mergers) Denmark, Spain, 
Netherlands, Italy, 
Portugal 
10. Reducing supply or funding for long-term care Netherlands, Italy 
Change service mix 
(increase or 
decrease depth) 
+ + - 
11. Increasing supply and accessibility of primary care to substitute for hospital 
care 
England, France, 
Netherlands, Italy, 
Portugal 
Value-based + ? ? 12. Introducing HTA to define coverage (all types of benefits including services) Spain 
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Health System 
Domain Affected 
Type of Effect 
Direction of Effect on 
Description of Policy Type Countries 
Output Equity Cost 
changes 
(increase or 
decrease depth) 
13. Introducing HTA to define coverage of drugs and/or devices Spain, France, Italy 
14. Using HTA to identify services for disinvestment Spain, France, 
Height of 
coverage and 
access to services 
 
Reduce user 
charges 
(increase height) 
+ + + 
Remove or decrease user charges for: 
15. Hospital and/or specialist care Denmark, Netherlands, 
Italy 
16. Primary care (in Netherlands, primary care consultations excluded from 
deductible, charges for mental health reversed in 2014) 
Netherlands 
17. Decreasing or abolishing user charges for vulnerable populations Denmark, France 
Increase user 
charge exemptions 
(increase height) 
+ + + 
18. Expanding user charge exemptions for vulnerable populations (e.g. based on 
age, income, employment status, health status) or reducing exemptions for 
wealthier populations 
France, Spain, 
Netherlands, Portugal 
Increase user 
charges 
(decrease height) 
- - - 
Introduce or increase user charges for: 
19. Hospital and/or specialist care Denmark, France, 
Netherlands, Italy, 
Portugal 
20. Primary care (in Netherlands, mental health only) Netherlands, Portugal 
21. Drugs and/or devices Denmark, Spain, France, 
Italy, Portugal 
22. Long-term care Netherlands 
23. Dental care Denmark 
24. Introducing / increasing overall deductibles (for all levels of care and types of 
services) 
Netherlands 
Reduce user charge - - - 25. Introducing or increasing user charges for vulnerable populations or removing Denmark 
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Health System 
Domain Affected 
Type of Effect 
Direction of Effect on 
Description of Policy Type Countries 
Output Equity Cost 
exemptions 
(decrease height) 
exemptions 
Value-based 
changes 
(increase or 
decrease height) 
+ ? ? 
26. Introducing or increasing value-based user charges (e.g. non-urgent use of ED, 
drugs with limited effectiveness, inappropriate service utilization, etc.)  
France, Italy 
Provider 
payment and 
prices 
Increase provider 
prices 
+ ? + 27. Increasing funding for or prices of primary care 
Netherlands (2010) 
Reduce provider 
prices 
? ? - 
28. Decreasing or freezing funding for or prices of primary care Netherlands (2008) 
29. Reduce hospital expenditure through budget caps or payment scheme reforms 
France, Netherlands, 
Italy, Portugal 
30. Reduce hospital expenditure through price cuts 
Denmark, England, 
France, Netherlands 
31. Increase competition among payers Netherlands 
Reduce health 
worker incomes 
? ? - 
32. Introducing measures to control health worker incomes (salary or fee-for-
service cuts, freezes or slowed increases, increased social contributions, 
increasing overtime shifts, etc.) 
Denmark, Spain, England, 
France, Netherlands, 
Italy, Portugal 
Reduce health 
technology prices 
+ + - 
33. Generic substitution 
Spain, France, 
Netherlands, Portugal 
34. Reduce drug or device prices through direct cuts or indirect policies (e.g. 
increased competition, centralized procurement, tendering, reference pricing 
etc.) 
Denmark, England, Spain, 
France, Netherlands, 
Italy, Portugal 
Provider 
structure and 
 Cut overhead ? ? - 35. Reducing provider administrative budgets or staff 
Denmark, England, 
Netherlands, Portugal 
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Health System 
Domain Affected 
Type of Effect 
Direction of Effect on 
Description of Policy Type Countries 
Output Equity Cost 
procurement 
36. Centralization of procurement of medical supplies 
England, Spain, France, 
Italy, Portugal 
Cut provider 
personnel numbers 
 
- ? - 
37. Introducing controls of health worker staff levels (cuts, recruitment freezes, 
non-renewal of temp contracts, etc.)  
England, Spain, Italy, 
Portugal 
Change skill mix + ? - 
38. Strengthening the role of nurses to substitute of doctors with nurses in primary 
care 
Netherlands, Portugal 
Cut capital 
investment 
- ? - 39. Reducing or delaying publicly financed capital investments in hospitals 
Denmark, England, Spain, 
Netherlands 
Service provision 
and quality 
Improve quality + ? ? 
40. Introducing or expanding measures to encourage evidence-based prescribing of 
drugs and avoid errors (INN, e-prescriptions, guidelines, etc.) 
Denmark, Spain, Portugal 
41. Adding new criteria to HTA or expand scope France 
42. Introducing or expanding measures to encourage evidence-based practice 
Denmark, France, Italy, 
Portugal 
43. Introducing additional e-health systems to facilitate information exchange, 
improve quality and reduce waste 
Denmark, France, 
Portugal 
44. Incentivize treatment and management of chronic patients France, Netherlands 
Overall 
Cut health system 
overhead 
? ? - 
45. Restructuring Ministries or other public agencies to reduce overhead and 
administrative costs 
Denmark, England 
Source: Authors based on Maresso et al. and Thomson et al. [3,4] 
Note: “+” denotes increases, “-“ decreases and “?” uncertain effects 
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Appendix 2: Summary of user charges introduced since 2008 by level of care and type of charge 
Level of Care and Type of 
Service or Good 
Type of Charge Countries and Type of Change 
Hospital in-patient stay Co-payment France (2010): from EUR16 to 18 per day for all hospital stays 
Netherlands (2012): introduction of co-payment of EUR145 / month 
for stay in mental care hospital (abolished in 2014) 
Hospital emergency services Co-payment Portugal (2011-13): depending on type of emergency, from EUR8.60 
- 9.60 to EUR 15 - 20.60 and future inflation-indexed increases. 
Italy (2011): increase to a minimum of EUR25 for non-urgent use, 
amount set by region (value-based charge) 
Outpatient specialist services Co-payment Denmark (2012): introduction for IVF and sterilization 
Netherlands (2012): introduction of EUR100 to 200 per secondary 
mental health treatment (abolished in 2014) 
Portugal (2011-13): increase from EUR4.60 to 7.75 for all specialist 
consultations and future inflation-indexed increases. 
France: 
Italy (2011): increase to a minimum of EUR10 nationally, with 
remaining amount set by region  
Primary care Co-payment Netherlands (2012): increase from EUR10 to 20 per primary mental 
health care consultation (abolished in 2014) 
Portugal (2011-13): from EUR2.25 to EUR 5 for GP consultations and 
up to EUR 10 for other primary care services and future inflation-
indexed increases. 
Devices Co-insurance Spain (2012): Introduction for prostheses, depending on category of 
coverage 
France (2010): increase from 35% to 40% for all devices, subject to 
exceptions approved by sickness funds 
Netherlands (2013): introduction of 25% for hearing aids (replacing 
varying levels of co-payments) 
Devices Co-payment Netherlands (year not specified): introduction of EUR141 per pair of 
orthopaedic shoes for adults and EUR57 for children aged <16 years 
Pharmaceuticals Co-insurance Denmark (2008-13): slight increases of ceilings for decreasing co-
insurance rate (from 100% for annual costs <DKK915 to 15% for 
costs >DKK3,235 
Spain: increase in co-insurance rate from 40% to 40 – 60%, 
depending on type of drug 
France (2010): 65% to 70% for less effective drugs (value-based 
charge) 
Portugal (2010-11): coinsurance applied to over-the-counter drugs 
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and pharmaceuticals for mental health conditions; co-insurance 
rates increased from 0 to 80% depending on the type of drug to 10 
to 85% (but decrease of co-insurance rate for generics) 
Pharmaceuticals Co-payment Denmark (2012): slight increase for over-the-counter drugs 
Spain (2012): Introduction for prescription drugs, depending on 
region and category of coverage 
Italy (2008-11): introduction in four regions for outpatient 
prescriptions 
Long-term care Co-insurance Netherlands (2013): increase of co-insurance rates 
Dental care Co-payment Denmark (2013): slight increase 
All, subject to exceptions Deductible Netherlands: repeated increases from EUR 150 / year in 2008 to EUR 
350 in 2013 
All, subject to exceptions Co-insurance France (2009): Increase for care not compliant with agreed 
pathways from 40% to 70% (value-based charge) 
Related non-healthcare 
services 
Co-payment Denmark (2013): introduction for translation services for migrant 
groups 
Source: Authors’ analysis based on Maresso et al.[3] and Mutual Information System on Social Protection (MISSOC) [37,38] 
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Appendix 3: Summary of changes to user charge exemptions and protection mechanisms 
Type of Exemption or Protection Countries and Targeted Populations 
Exemptions from all user charges Italy (2008-11): varying arrangements by region, but charges 
generally based on household income; increase of age 
threshold for exemption for people receiving the min. 
pension from 60 to 65 years  
Portugal (2012): expansion based on income, health status 
(e.g. people with chronic conditions), disability, age (e.g. 
children) and employment status (e.g. unemployed, fire 
fighters) to cover about 70% of the population 
Expansion of publicly funded statutory insurance coverage 
and private insurance for user charges 
France (2009): expansion of low-income population eligible 
for statutory coverage (CMU) and complementary insurance 
covering user charges (CMU-C) 
France (2011): removal of deductible for undocumented 
migrants 
Income-based co-insurance rates and monthly caps for 
prescription drugs 
Spain (2012): introduction of varying rates from 10 to 60% 
and monthly caps ranging from EUR8 to EUR61 for annual 
incomes between EUR18,000 to 100,000 
Insurance premium subsidies Netherlands (2011-13): gradual reduction of subsidies for 
purchase of insurance and lowering of income threshold for 
eligibility. However, reductions less significant for lower 
than higher incomes. 
Exemptions of services from deductible Netherlands (year not specified): exclusion of GP 
consultations, maternity care and paediatric care from 
overall deductible 
Source: Authors’ analysis based on Maresso et al.[3] and Mutual Information System on Social Protection (MISSOC) [37,38] 
 
